Data underscore the vast potential of allogeneic, non-HLA matched, T regulatory cell therapy program in addressing diseases driven by dysregulated inflammation HOUSTON, Dec. 10, 2024 (GLOBE NEWSWIRE) ...
Some results have been hidden because they may be inaccessible to you